CESCA THERAPEUTICS INC. Business Finance Contracts & Agreements
83 Contracts & Agreements
- Contribution Agreements (1 contract)
- Credit Agreements (7)
- Debenture Agreements (3)
- Escrow Agreements (3)
- Investor Rights Agreements (1)
- Loan Agreements (1)
- Note Agreements (14)
- Purchase Agreements (15)
- Registration Rights Agreements (3)
- Release Agreements (6)
- Security Agreements (2)
- Stock Agreements (6)
- Subscription Agreements (1)
- Underwriting Agreements (1)
- Warrant Agreements (19)
- Amendment No. 4 to Convertible Promissory Note, dated July 31, 2023, between ThermoGenesis Holdings, Inc. and Orbrex (USA) Co. Limited (Filed With SEC on August 3, 2023)
- Form of Registration Rights Agreement (Filed With SEC on March 21, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on March 21, 2023)
- Form of Warrant Amendment Agreement (Filed With SEC on March 21, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on March 21, 2023)
- Form of Common Warrant (Filed With SEC on March 21, 2023)
- Amendment No. 3 to First Amended and Restated Revolving Credit Agreement, dated March 6, 2023, between ThermoGenesis Holdings, Inc. and Boyalife Group Inc (Filed With SEC on March 10, 2023)
- Amendment No. 2 to Second Amended and Restated Convertible Promissory Note, dated March 6, 2023, between ThermoGenesis Holdings, Inc. and Boyalife Group Inc (Filed With SEC on March 10, 2023)
- Amendment No. 3 to Convertible Promissory Note, dated January 31, 2023, between ThermoGenesis Holdings, Inc. and Orbrex (USA) Co. Limited (Filed With SEC on February 6, 2023)
- Form of Common Warrant (Filed With SEC on October 17, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on October 17, 2022)
- Amendment No. 2 to Convertible Promissory Note, dated July 25, 2022, between ThermoGenesis Holdings, Inc. and Orbrex (USA) Co. Limited (Filed With SEC on July 28, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on April 29, 2022)
- Form of Common Warrant (Filed With SEC on April 29, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on April 29, 2022)
- Amendment No. 2 to First Amended and Restated Revolving Credit Agreement, dated March 4, 2022, between ThermoGenesis Holdings, Inc. and Boyalife Asset Holding II, Inc (Filed With SEC on March 8, 2022)
- Amendment No. 1 to Second Amended and Restated Convertible Promissory Note, dated March 4, 2022, between ThermoGenesis Holdings, Inc. and Boyalife Asset Holding II, Inc (Filed With SEC on March 8, 2022)
- Payment Protection Program Loan (PPP Loan) between ThermoGenesis Holdings, Inc. and Comerica Bank dated April 21, 2020 (Filed With SEC on August 14, 2020)
- Form of Stock Option Agreement (Filed With SEC on June 9, 2020)
- Form of Securities Purchase Agreement, dated as of March 25, 2020, between ThermoGenesis Holdings, Inc. and the Purchasers identified on the signature pages thereto (Filed With SEC on March 27, 2020)
- Form of Stock Option Award Agreement (Filed With SEC on January 3, 2020)
- Contribution Agreement, dated November 22, 2019, between ThermoGenesis Holdings, Inc. and ImmuneCyte Life Sciences Inc (Filed With SEC on November 27, 2019)
- Amendment No. 1, dated July 23, 2019, to the Convertible Promissory Note, dated January 29, 2019 between Cesca therapeutics Inc. and Orbrex USA Co (Filed With SEC on November 19, 2019)
- Amendment No. 1 to the Convertible Promissory Note, Dated July 23, 2019 between Cesca therapeutics Inc. and Orbrex USA Co (Filed With SEC on August 13, 2019)
- Amendment No. 1 to the Convertible Note Agreement dated as of July 23, 2019, between Cesca Therapeutics Inc. and Orbrex USA Co (Filed With SEC on July 29, 2019)
- Securities Purchase Agreement, dated as of July 23, 2019, between Cesca Therapeutics Inc. and the Purchaser identified on the signature pages thereto (Filed With SEC on July 29, 2019)
- Form of Note (Filed With SEC on July 29, 2019)
- Securities Purchase Agreement, dated as of April 18, 2019, between Cesca Therapeutics Inc. and the Purchaser identified on the signature pages thereto (Filed With SEC on April 25, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on April 25, 2019)
- Securities Purchase Agreement, dated as of January 29, 2019, between Cesca Therapeutics Inc. and the Purchasers identified on the signature pages thereto (Filed With SEC on January 31, 2019)
- Form of Note (Filed With SEC on January 31, 2019)
- Investors Rights Agreement, dated January 1, 2019, among CARTXpress Bio, Inc., Bay City Capital Fund V, L.P., and Bay City Capital Fund V Co-Investment Fund, L.P (Filed With SEC on January 4, 2019)
- Form of Stock Option Agreement (Filed With SEC on December 19, 2018)
- Exhibit 10.1 Securities Purchase Agreement, dated as of August 28, 2018, between Cesca Therapeutics Inc. and the Purchasers identified on the signature pages thereto (Filed With SEC on August 29, 2018)
- Exhibit 4.1 Form of Pre-Funded Warrant (Filed With SEC on August 29, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on May 14, 2018)
- Form of Pre-Funded Warrant (Filed With SEC on May 14, 2018)
- Form of Common Warrant (Filed With SEC on May 14, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on May 8, 2018)
- Form of Pre-Funded Warrant (Filed With SEC on May 8, 2018)
